Omeros (OMER) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.72% |
| Dec 31, 2025 | 69.40% |
| Sep 30, 2025 | 43.43% |
| Jun 30, 2025 | -8.16% |
| Mar 31, 2025 | 29.03% |
| Dec 31, 2024 | 23.65% |
| Sep 30, 2024 | 31.01% |
| Jun 30, 2024 | 36.90% |
| Mar 31, 2024 | -49.57% |
| Dec 31, 2023 | 119.74% |
| Sep 30, 2023 | 11.57% |
| Jun 30, 2023 | 35.15% |
| Mar 31, 2023 | -87.57% |
| Dec 31, 2022 | -85.51% |
| Sep 30, 2022 | 20.63% |
| Jun 30, 2022 | 33.45% |
| Mar 31, 2022 | -55.88% |
| Dec 31, 2021 | 83.32% |
| Sep 30, 2021 | 23.49% |
| Jun 30, 2021 | 54.79% |
| Mar 31, 2021 | 17.65% |
| Dec 31, 2020 | 1.43% |
| Sep 30, 2020 | -59.16% |
| Jun 30, 2020 | 10.68% |
| Mar 31, 2020 | 16.80% |
| Dec 31, 2019 | -36.33% |
| Sep 30, 2019 | -8.90% |
| Jun 30, 2019 | -0.63% |
| Mar 31, 2019 | 18.02% |
| Dec 31, 2018 | 13.71% |
| Sep 30, 2018 | 25.91% |
| Jun 30, 2018 | -17.44% |
| Mar 31, 2018 | -0.37% |
| Dec 31, 2017 | -8.20% |
| Sep 30, 2017 | -14.96% |
| Jun 30, 2017 | 51.11% |
| Mar 31, 2017 | -11.53% |
| Dec 31, 2016 | -23.01% |
| Sep 30, 2016 | -44.64% |
| Jun 30, 2016 | -21.80% |
| Mar 31, 2016 | 60.65% |
| Dec 31, 2015 | 25.04% |
| Sep 30, 2015 | 15.08% |